Signs of neuroinflammation outweigh neurodegeneration as predictors for early conversion to MS

[1] Marcus JF(2013)Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis The Neurohospitalist 3 65-80

[2] Waubant EL(2014)Multiple sclerosis: a review of the disease and treatment options Consult Pharm 29 469-479

[3] Sturm D(2015)The Montreal Cognitive Assessment (MoCA) in multiple sclerosis: relation to clinical features J Mult Scler 2 135-493

[4] Gurevitz SL(2017)Cognitive impairment and structural brain changes in patients with clinically isolated syndrome at high risk for multiple sclerosis J Neurol 264 482-1017

[5] Turner A(2016)Width of the third ventricle as assessed by transcranial sonography is associated with future relapses in mild multiple sclerosis J Neurol Neurosci 7 S3-2504

[6] Charvet LE(2009)Transcranial brain sonography findings predict disease progression in multiple sclerosis Neurology. 73 1010-546

[7] Hynčicová E(2016)Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German–Austrian retrospective multicenter study in patients with a clinically isolated syndrome J Neurol 263 2499-931

[8] Vyhnálek M(2012)Astrocyte and macrophage regulation of YKL-40 expression and cellular response in neuroinflammation Brain Pathol 22 530-1261

[9] Kalina A(2015)Chitinase 3-like 1: Prognostic biomarker in clinically isolated syndromes Brain. 138 918-431

[10] Martinkovič L(2015)Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis Mult Scler 21 1251-1452

[1] Marcus JF(2013)Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis The Neurohospitalist 3 65-80

[2] Waubant EL(2014)Multiple sclerosis: a review of the disease and treatment options Consult Pharm 29 469-479

[3] Sturm D(2015)The Montreal Cognitive Assessment (MoCA) in multiple sclerosis: relation to clinical features J Mult Scler 2 135-493

[4] Gurevitz SL(2017)Cognitive impairment and structural brain changes in patients with clinically isolated syndrome at high risk for multiple sclerosis J Neurol 264 482-1017

[5] Turner A(2016)Width of the third ventricle as assessed by transcranial sonography is associated with future relapses in mild multiple sclerosis J Neurol Neurosci 7 S3-2504

[6] Charvet LE(2009)Transcranial brain sonography findings predict disease progression in multiple sclerosis Neurology. 73 1010-546

[7] Hynčicová E(2016)Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German–Austrian retrospective multicenter study in patients with a clinically isolated syndrome J Neurol 263 2499-931

[8] Vyhnálek M(2012)Astrocyte and macrophage regulation of YKL-40 expression and cellular response in neuroinflammation Brain Pathol 22 530-1261

[9] Kalina A(2015)Chitinase 3-like 1: Prognostic biomarker in clinically isolated syndromes Brain. 138 918-431

[10] Martinkovič L(2015)Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis Mult Scler 21 1251-1452